Thermo Fisher Scientific Recognizes Tandem Mass Tag Grant Award Winners at ASMS 2017

International competition rewards top proteomics researchers for outstanding innovation and impact

Monday, June 5, 2017 8:20 am EDT

Dateline:

INDIANAPOLIS – ASMS 2017
"We are excited to offer the TMT Research Grant Awards for the third consecutive year"

Thermo Fisher Scientific, the world leader in serving science, will recognize the winners of the 2016 Thermo Scientific Tandem Mass Tag (TMT) Research Award at a breakfast workshop held on June 6, 2017 during the 65th American Society of Mass Spectrometry (ASMS) Conference in Indianapolis. Now in its third year, the research competition selects scientists from a pool of international applicants based on innovation and the potential impact of their work in proteomics using these tandem mass tags (TMT). The proprietary TMT reagents are exclusively licensed to Thermo Fisher Scientific by Proteome Sciences, PLC.

Gold, silver and bronze winners receive awards of TMT and other mass spectrometry-related reagents, valued at $10,000, $7,500 or $5,000, respectively. Winners will use these reagents to quantify, normalize and streamline global protein expression studies using mass spectrometry.

A panel of judges from Thermo Fisher and Proteome Sciences, PLC – which licensed the TMT reagents used for awards – selected the four recipients from among a group of competitive submissions based on the scientific merit of their proposals. This year, there was a tie for the bronze award.

  • Roman Fischer, University of Oxford, Oxford, England (Gold recipient)
  • Kathryn Lilley, University of Cambridge, Cambridge, England (Silver recipient)
  • Kilian Huber, University of Oxford, Oxford, England (co-Bronze recipient)
  • Ashok Reddy, Oregon Health & Science University, Portland, Oregon (co-Bronze recipient)

“We are excited to offer the TMT Research Grant Awards for the third consecutive year,” said Monica O'Hara-Noonan, market development manager, protein and cell analysis, Thermo Fisher. “The number of applications doubled from last year, including a wide range of diverse submissions that give us a thrilling glimpse into the future of multiplex proteomics. We look forward to seeing what these four innovative award-winners achieve with our latest instrumentation and reagents.”

“Thermo Fisher has become an “all-inclusive” proteomics supplier, providing not only instrumentation and software, but also a comprehensive set of reagents and materials for sample generation and preparation, which we use on a daily basis,” said Roman Fischer, faculty head of the discovery proteomics facility at the University of Oxford, and a 2017 TMT Gold Level Grant Award recipient. “In particular, the TMT reagents will allow us to generate deep multiplexed proteomes from limited material without compromising quantitation.”

For more information, visit http://www.thermofisher.com/tmtgrant.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $18 billion and more than 55,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.

###

Thermo Fisher Tweets

Introducing the first NGS-based IVD test for detection of genetic mutations in #NSCLC - Oncomine Dx Target Test… https://t.co/jR0BLLcoT0-3 hours 7 min ago
Hi, Can you plz share serial # of your Vanquish system & your location? We can connect you with the right team. Thanks.-6 hours 57 min ago
Scientists will do just about anything to get an automated cell counter! https://t.co/iWeiF2rvuX See the rebellion. https://t.co/8d3TauNecG-7 hours 29 min ago
What’s the advantage of exceptionally bright readouts for better discrimination of cell subpopulations?… https://t.co/0LbS3hM38m-7 hours 29 min ago
We've just received FDA approval for the first NGS-based IVD test for detection of genetic mutations in #NSCLC https://t.co/uXlmLlmTq1-1 day 1 hour ago